JPX · 4554.T
Fuji Pharma Co., Ltd.
¥1,870+¥39 (+2.13%)
Fuji Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.92% below the high.
Loading market information…
JPX · 4577.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Daito Pharmaceutical Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Daito Pharmaceutical Co.,Ltd.’s forward annual dividend is ¥40 per share, paid semi-annual. The forward yield is 3.02% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Daito Pharmaceutical Co.,Ltd.’s next earnings report is currently expected on Jan 8, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Daito Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Daito Pharmaceutical Co.,Ltd. is a global entity primarily involved in the creation and sale of a diverse range of pharmaceutical products. Their offerings span active pharmaceutical ingredients (APIs) and chemical intermediates, alongside both prescription and over-the-counter (OTC) medications, and home-delivered medicines. These products are available in various formats, including tablets, capsules, lozenges, granules, and powdered forms. Beyond its own brand, the company also provides contract manufacturing services, developing medicinal formulations for other pharmaceutical firms. Additionally, Daito Pharmaceutical markets health food products. Established in 1942, it was initially known as Daito Corporation, changing to its current name in 1992, and maintains its headquarters in Toyama, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Apr 14, 2025 |
| ¥10 |
| ¥12.03B+5.8% vs estimate |
| Q2 2024 | Jan 10, 2025 | ¥9 | ¥11.91B-6.09% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,870+¥39 (+2.13%)
Fuji Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.92% below the high.
¥355-¥17 (-4.57%)
3-D Matrix, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.23% below the high.
¥1,368+¥1 (+0.07%)
Charm Care Corporation’s quoted price sits in the upper half of its reported 52-week range, 8.49% below the high.
¥2,668-¥15 (-0.56%)
Medikit Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 13.8% below the high.
¥839+¥9 (+1.08%)
Koa Shoji Holdings Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 8.71% below the high.
¥1,217-¥16 (-1.3%)
WIN-Partners Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.3% below the high.
¥1,711+¥10 (+0.59%)
Mizuho Medy Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.35% below the high.
¥561¥0 (0.0%)
Seikagaku Corporation’s quoted price sits in the lower half of its reported 52-week range, 31.59% below the high.
